ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1917

Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells

Stinne Greisen1,2, Yan Yan3, Aida Hansen1, Morten Venø3, Jens Randel Nyengaard4, Malene Hvid5, Arlene Sharpe6, Jørgen Kjems3 and Bent Deleuran7,8, 1Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Interdisciplinari Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark, 4Clinical Medicine, Electro Microscopy Laboratory, Aarhus University Hospital, Aarhus, Denmark, 5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 6Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 7Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 8Department of Biomedicine, Aarhus University, Aarhus, Denmark

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: microparticles and rheumatoid arthritis (RA), MicroRNA, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Programmed death-1 (PD-1) is a central marker of T cell exhaustion. Exhausted T cells are present in inflammatory conditions, where they fail to eliminate the disease, and contribute to development of chronicity. They are suggested associated with a favorable prognosis in rheumatoid arthritis (RA), yet this is not fully elucidated 1. Extracellular vesicles (EVs) carrying proteins and microRNAs (miRNAs), among other constituents have been recognized as an important route of communication in the microenvironment.

Methods: Plasma and synovial fluid from RA patients were examined for the presence of EVs by capturing EVs on CD63 coated beads. EVs were furthermore isolated from supernatants from synovial fluid mononuclear cell (SFMC) and peripheral blood mononuclear cell (PBMC) cultures and characterized. The presence of PD-1 in EVs was examined by immuno-gold electron microscopy (EM), ELISA and western blotting. EVs purified from RA and healthy control (HC) PBMC cultures were co-cultured with lymphocytes and U937 cells (a cell line negative for PD-1), and EVs from WT mice were co-cultured with cells from PD-1-/- mice. PD-1 expression and cell proliferation of the exposed cells were analyzed. Finally, miRNA expression in EVs from cultured RA and HC cells was investigated by sequencing.

Results: PD-1 was detected in EVs in plasma and synovial fluid from RA patients. The presence of PD-1+ EVs in RA and HC cell culture supernatants was confirmed with immuno-gold EM and western blotting. Co-culturing these EVs with other cells induced PD-1 on the surface of lymphocytes and U937 cells. PD-1 was furthermore induced on PD-1-/- cells, when these were co-cultured with EVs from WT mice. EVs from RA PBMCs increased recipient cell proliferation, compared with both EVs from HC PBMCs and cells without EVs. This was not changed by addition of recombinant PD-L1. MicroRNAs repressing expression of the co-inhibitory receptors PD-1, TIM-3 and CTLA-4, all associated with an exhausted T cell profile, were up-regulated in EVs from stimulated PBMC cultures, however not in EVs from RA SFMCs. In EVs from non-stimulated RA PBMC cultures, miRNAs repressing the exhausted T cell pathway were down-regulated compared to EVs from HC cultures, suggesting that RA PBMCs in a steady-state aim to transfer information maintaining an exhausted T cell profile.

Conclusion: EVs from RA PBMCs carry and transfer PD-1 and incorporate less miRNAs repressing the PD-1 pathway and other markers of T cell exhaustion. Despite this, EVs from RA PBMCs increase proliferation of recipient cells in vitro. In addition, EVs from RA synovial cells express low levels of miRNA that regulate PD-1, TIM-3 and CTLA-4, facilitating continuous T-cell exhaustion. In conclusion this suggests that EVs are pro-inflammatory in RA, and contribute substantially to the development of chronicity. 1. McKinney, E. F., et al. Nature 523, 612–616 (2015).


Disclosure: S. Greisen, None; Y. Yan, None; A. Hansen, None; M. Venø, None; J. R. Nyengaard, None; M. Hvid, None; A. Sharpe, None; J. Kjems, None; B. Deleuran, None.

To cite this abstract in AMA style:

Greisen S, Yan Y, Hansen A, Venø M, Nyengaard JR, Hvid M, Sharpe A, Kjems J, Deleuran B. Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-cells-produce-extracellular-vesicles-that-incorporate-pd-1-and-micrornas-targeting-the-pd-1-pathway-in-surrounding-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-cells-produce-extracellular-vesicles-that-incorporate-pd-1-and-micrornas-targeting-the-pd-1-pathway-in-surrounding-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology